Access count of this item: 187
Full metadata record
|dc.description.abstract||1. 13 (81.3 %) of 16 patients with benign prostatic hyperplasia improved when treated chiefly by estrogen, 3 (75 %) of 4 patients improved when treated by deep x-ray therapy, and all 6 patients treated by a combination of the two methods improved. These clinical improvements were temporary. 2. The results of a comparative study in several methods on the treatment of 95 patients with benign prostatic hyperplasia were as follows: the proportion of recovery was 95 per cent by prostatectomy, 79 per cent by hormonal and x-ray therapy, 58 per cent by the other conservative therapy, and the lowest was 18 per cent in the patients who were neither treated nor visited again. 3. In 2-8 years after the treatment, 40 of 95 cases were examined. 40 per cent of the patients who were treated by the use of hormone or x-ray, and 80 per cent of the patients who were treated by other conservative therapy had recurrance after the suspension of treatment. 4. It seems that so-called hormonal treatment on patients with benign prostatic hyperplasia can produce only improvement in their subjective symptoms. The mechanisms why the hormonal therapy is more effective than other conservative therapy to this disease was also discussed in this paper. (It is a pleasure to aknowledge my indebtedness to Dr. T. Inada, Professor and Head of the Department of Urology, Kyoto University) Original articles of these papers were published in Japan in the following Journal: Acta Urologica Vol. 1, No.1, p. 22- 28, 1955 Q Vol. 1, No.2, p. 85-- 95, 1955 Q Vol. 1, No.4, p.219-226, 1955 Q Vol. 2, No.1, p. 13- 18, 1956 Q Vol. 2, No.2, p. 55- 66, 1956||ja|
|dc.title.alternative||Studies on Benign Prostatic Hyperplasia V. Conservative Treatment of Benign Prostatic Hyperplasia||ja|
|dc.type.niitype||Departmental Bulletin Paper||ja|
|dc.address.alternative||the Department of Urology, Faculty of Medicine, Kyoto University||ja|
|Appears in Collections:||Vol.2 No.2|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.